- Advertisement -
- Advertisement -

Related

Rhenmans segertåg fortsätter

Latest Report

- Advertisement -

Stockholm (HedgeNordic.com) – Rhenman & Partners hedgefond, Rhenman Healthcare Equity L/S, har återigen visat framfötterna. Efter ett osedvanligt starkt fjolår där fonden steg med dryga 55%, har 2014 visat på fortsatta framgångar. Under augusti månad steg fonden 7,45% vilket tar avkastningen för helåret till 20,27%. Fonden har två år i rad utnämnts till bästa aktiehedgefond vid Nordic Hedge Awards.

I sitt månadsbrev skriver förvaltaren att klimatet inom biotech-sektorn gynnades kraftigt av att läkemedelbolaget Roche lade ett bud på Intermune under månaden. Fondens innehav i Intermune var dock försumbart och istället gynnades fondens utveckling av innehav i Salix (uppköpssekulationer samt förhoppningar utökade godkännanden för läkemedlen Xifaxan och Relistor), Gilead (fortsatt extremt starka försäljningssiffror för hepatit C läkemedlet Sovaldi och förhoppningar om ökad acceptans för preparatet utanför USA) samt Biomarin (som anses vara en uppköpskandidat som inte hängt med utvecklingen för biotech bolag). Bland negativa resultatbidrag märktes innehav som Meda (svaga resultat), Thoratec (svaga resultat) samt Revance (oro för krav på ökad dokumentation vad avser deras botox liknande produkter).

Förvaltaren har en fortsatt positiv syn på fonden för helåret trots fortsatt geopolitisk oro.

Bild: (c) ollyy—shutterstock.com 

 

Subscribe to HedgeBrev, HedgeNordic’s weekly newsletter, and never miss the latest news!

Our newsletter is sent once a week, every Friday.

Kamran Ghalitschi
Kamran Ghalitschi
Kamran has been working in the financial industry since 1994 and has specialized on client relations and marketing. Having worked with retail clients in asset management and brokerage the first ten years of his career for major European banks, he joined a CTA / Managed Futures fund with 1,5 Billion USD under management where he was responsible for sales, client relations and operations in the BeNeLux and Nordic countries. Kamran joined a multi-family office managing their own fund of hedgefunds with 400 million USD AuM in 2009. Kamran has worked and lived in Vienna, Frankfurt, Amsterdam and Stockholm. Born in 1974, Kamran today again lives in Vienna, Austria.

Latest Articles

Fenja Capital Deepens Bench as Analyst Moves to Full-Time Role

After earning his Master’s degree in Economics from Aalborg University, Anders Madsen has transitioned from a part-time role to a full-time analyst position at...

Accendo-Backed SSH Secures Major Investment from Leonardo

While public and policy discussions around defence often focus on conventional weapons, many of today’s most active and frequent battles are unfolding in cyberspace....

Swedbank Robur Strengthens Private Equity Team

Swedbank Robur has appointed Lorenzo Gregory Sormani as co-portfolio manager of its private equity fund, Swedbank Robur Alternative Equity I, joining Senior Portfolio Manager...

Beyond Renewables: Coeli Fund Taps Into the Broader Electrification Race

Earlier this year, portfolio managers Vidar Kalvoy and Joel Etzler renamed their fund from Coeli Renewable Opportunities to Coeli Energy Opportunities – a move...

Three Danish Hedge Funds Recognized by the Hedge Fund Journal

Three Danish hedge funds have been recognized at the 2025 Hedge Fund Journal CTA and Discretionary Trader Awards. Two funds managed by Danske Bank...

Private Equity in Transition: Challenges and Opportunities

Private equity has matured into a mainstream – if not cornerstone – allocation for institutional investors. Following years of record fundraising and valuation expansion,...

Allocator Interviews

In-Depth: High Yield

Voices

Request for Proposal

- Advertisement -
HedgeNordic
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.